Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Neuromuscular Disorders : NMD|May 19, 2019
Polyradiculoneuropathy in dourine-affected horsesBayasgalan Mungun-Ochir, Noriyuki Horiuchi, Adilbish Altanchimeg, et al.
Parasitology International|December 7, 2023
Expression profile analysis of the transient receptor potential (TRPM) channel, a possible target of praziquantel in Schistosoma japonicumKaho Shinozaki, Masashi Kirinoki, Wanlop Atcharaphan, et al.
Oncotarget|December 22, 2017
Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancerRin Ogiya, Naoki Niikura, Nobue Kumaki, et al.
JMA Journal|November 9, 2023
Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health ServicesShin Takayama, Takayuki Kinoshita, Sho Shiino, et al.
Archives of Pharmacal Research|July 23, 2015
Drug compound characterization by mass spectrometry imaging in cancer tissueHo Jeong Kwon, Yonghyo Kim, Yutaka Sugihara, et al.
Cancer Research|April 17, 2002
Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMGMasato Takahashi, Naohiko Seki, Toshinori Ozaki, et al.
Breast (Edinburgh, Scotland)|February 25, 2021
Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN studyTakashi Ishikawa, Kentaro Sakamaki, Kazutaka Narui, et al.
Eclinicalmedicine|August 7, 2024
Eribulin versus S-1 as first or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a non-inferiority, randomised, controlled, open-label, phase 3 trialMasato Takahashi, Yuichiro Kikawa, Kosuke Kashiwabara, et al.
Japanese Journal of Clinical Oncology|December 14, 2004
Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tabletsWasaburo Koizumi, Hiroshi Toma, Ken-ichi Watanabe, et al.
Breast Cancer (Tokyo, Japan)|February 14, 2018
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)Shoichiro Ohtani, Takahiro Nakayama, Tetsuhiro Yoshinami, et al.
Pageof 14